Merck to Acquire EyeBio in Potential $3 Billion Deal
- May 31, 2024
Merck & Co. is planning to acquire ophthalmology-focused biotechnology company EyeBio Ltd for as much as $3 billion, according to a May 29 announcement.
ARTICLE TAGS
You must be logged in to access this content.